Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Salivary gland cancer
ADR ID BADD_A08595
ADR Hierarchy
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.07      Malignant oral cavity neoplasms
07.21.07.008      Salivary gland cancer
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.13      Gastrointestinal neoplasms malignant and unspecified
16.13.12      Salivary gland neoplasms malignant
16.13.12.001      Salivary gland cancer
Description Tumors or cancer of the SALIVARY GLANDS. [MeSH]
MedDRA Code 10061934
MeSH ID D012468
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Malignant neoplasm of major salivary glands | Malignant neoplasm of other major salivary glands | Malignant neoplasm of parotid gland | Malignant neoplasm of salivary gland, unspecified | Malignant neoplasm of sublingual gland | Malignant neoplasm of submandibular gland | Malignant salivary gland cancer | Malignant salivary gland neoplasm | Parotid tumor malignant | Salivary gland cancer NOS | Salivary gland carcinoma | Parotid tumour malignant | Salivary gland cancer | Salivary Gland Neoplasms | Gland Neoplasm, Salivary | Gland Neoplasms, Salivary | Neoplasm, Salivary Gland | Salivary Gland Neoplasm | Neoplasms, Salivary Gland | Cancer of Salivary Gland | Salivary Gland Cancers | Cancer of the Salivary Gland | Salivary Gland Cancer | Cancer, Salivary Gland | Cancers, Salivary Gland
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00151Apixaban0.000043%
BADD_D00623Dexamethasone0.000218%
BADD_D01913Ranitidine0.000050%
BADD_D02236Tofacitinib0.000241%
BADD_D02464Fingolimod0.000241%
The 1th Page    1    Total 1 Pages